Filed Pursuant to Rule 424(b)(5)
Registration No. 333-257317
PROSPECTUS SUPPLEMENT
(To Prospectus dated June 23, 2021)
13,000,000 Shares
![LOGO](https://capedge.com/proxy/424B5/0001193125-22-219223/g373631g93w24.jpg)
Broadstone Net Lease, Inc.
Common Stock
Broadstone Net Lease, Inc., a Maryland corporation, is an internally-managed real estate investment trust (“REIT”) that acquires, owns, and manages primarily single-tenant, commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. We and Broadstone Net Lease, LLC, our operating partnership (the “OP”), have entered into forward sale agreements with each of Goldman Sachs & Co. LLC, Bank of Montreal, JPMorgan Chase Bank, N.A., and Truist Bank or their affiliates, which we refer to in this capacity as the “forward purchasers.” In connection with such forward sale agreements, the forward purchasers (or their affiliates) are borrowing from third parties and selling to the underwriters an aggregate of 13,000,000 shares of our common stock, par value $0.00025 per share (“common stock”) (or an aggregate of 1,950,000 shares of our common stock if the underwriters’ option to purchase additional shares is exercised in full) that will be sold in this offering.
We will not initially receive any proceeds from the sale of shares by the forward purchasers or their affiliates. We expect to physically settle the forward sale agreements and receive proceeds, subject to certain adjustments, from the sale of shares of our common stock that we issue to the forward purchasers upon one or more such physical settlements no later than August 10, 2023. Although we expect to settle the forward sale agreements entirely by the physical delivery of shares of our common stock for cash proceeds, we may also elect to cash or net share settle all or a portion of our obligations under the forward sale agreements, in which case we may receive, or we may owe, cash or shares of our common stock from or to the forward purchasers. See “Underwriting—Forward Sale Agreements” in this prospectus supplement for a description of the forward sale agreements.
If the forward purchasers or their affiliates do not deliver and sell all of the shares of our common stock to be sold by the forward purchasers to the underwriters, we will issue and sell to the underwriters a number of shares of our common stock equal to the number of shares of our common stock that the forward purchasers or their affiliates do not sell and the number of shares underlying the applicable forward sale agreements will be decreased in respect of the number of shares that we issue and sell.
Our common stock is listed on the New York Stock Exchange (the “NYSE”) under the symbol “BNL”. The last reported sale price of our common stock on the NYSE on August 9, 2022 was $22.03 per share.
Our articles of incorporation contain restrictions on the ownership and transfer of our common stock intended to assist us in maintaining our status as a REIT for federal and/or state income tax purposes. See “Restrictions on Ownership” in the accompanying prospectus.
Investing in our common stock involves a high degree of risk. Before buying any of our common stock you should carefully read the discussion of material risks of investing in our common stock in “Risk Factors” beginning on page S-6 of this prospectus supplement and page 4 of the accompanying prospectus, as well as those described in our most recent Annual Report on Form 10-K and other periodic reports filed with the Securities and Exchange Commission (the “SEC”) and incorporated herein by reference.
Neither the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.
| | | | | | | | |
| | Per Share | | | Total(1) | |
Public offering price | | $ | 21.35 | | | $ | 277,550,000 | |
Underwriting discounts and commissions(2) | | $ | 0.26 | | | $ | 3,380,000 | |
Proceeds to Broadstone Net Lease, Inc., before expenses(3) | | $ | 21.09 | | | $ | 274,170,000 | |
(1) | Assumes no exercise of the underwriters’ option to purchase additional shares as described below. |
(2) | See “Underwriting” for a description of all compensation payable to the underwriters. |
(3) | We expect to receive net proceeds from the sale of the shares of our common stock, before estimated fees and expenses, of approximately $277.5 million, upon full physical settlement of the forward sale agreements in one or more settlements, which we expect will occur by August 10, 2023. For the purpose of calculating the estimated aggregate proceeds to us, we have assumed the forward sale agreements will be fully physically settled at the initial forward sale price of $21.09 per share, which is the public offering price less the underwriting discounts shown above. The forward sale price is subject to adjustment pursuant to the forward sale agreements, and the actual proceeds, if any, will be calculated pursuant to the forward sale agreements. Although we expect to settle the forward sale agreements entirely by the full physical delivery of shares of our common stock in exchange for cash proceeds, we may elect cash settlement or net share settlement for all or a portion of our obligations under the forward sale agreements. See “Underwriting—Forward Sale Agreements” for a description of the forward sale agreements. |
We have granted the underwriters a 30-day option from the date of this prospectus supplement, exercisable in whole or in part from time to time, to purchase up to an additional 1,950,000 shares of our common stock at the price per share set forth above, less any dividends or distributions payable on the shares initially purchased by the underwriters but not payable on such additional shares. Upon any exercise of such option, we may elect that such additional shares of common stock be sold by the forward purchasers or their affiliates to the underwriters, in which case we will enter into additional forward sale agreements with the forward purchasers in respect of the number of shares that are subject to the exercise of such option. Unless the context requires otherwise, the term “forward sale agreements” as used in this prospectus supplement includes any additional forward sale agreements that we enter into in connection with the exercise, by the underwriters, of their option to purchase additional shares of our common stock. In the event that we enter into additional forward sale agreements and if the forward purchasers or their affiliates do not deliver and sell all of the shares of our common stock to be sold by them in connection with the exercise of such option, we will issue and sell to the underwriters a number of shares of our common stock equal to the number of shares that the forward purchasers or their affiliates do not deliver and sell, and the number of shares underlying the forward sale agreements will not be increased in respect of the number of shares that we issue and sell.
The underwriters expect to deliver the shares to purchasers on or about August 12, 2022 through the book-entry facilities of The Depository Trust Company.
Joint Book-Running Managers
| | | | | | |
Goldman Sachs & Co. LLC | | BMO Capital Markets | | J.P. Morgan | | Truist Securities |
The date of this prospectus supplement is August 10, 2022